참고문헌
- ACOG Committee Opinion: number 280, December 2002 (2002). The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Obstetrics Gynecol, 100, 1413-6. https://doi.org/10.1016/S0029-7844(02)02630-3
- Arab M, Noghabaei G, Kazemi SN (2014). Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005. Asian Pac J Cancer Prev, 15, 2461-64. https://doi.org/10.7314/APJCP.2014.15.6.2461
- Arab M, Yaseri M, Farzaneh M, et al (2012). The construction and validation of a new ovarian malignancy probability score (OMPS) for prediction of ovarian malignancy. Iranian J Cancer Prev, 3, 132-38.
- Arikan SK, Kasap B, Yetimalar H, et al (2014). Impact of prognostic factors on survival rates in patients with ovarian carcinoma. Asian Pac J Cancer Prev, 15, 6087-94. https://doi.org/10.7314/APJCP.2014.15.15.6087
- Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002). Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol, 20, 1248-59. https://doi.org/10.1200/JCO.20.5.1248
- Du Bois A, Quinn M, Thigpen T, et al (2005). 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Annals of oncology: official journal of the European Society for Medical Oncology / ESMO, 16,viii7-viii12.
- Earle CC, Schrag D, Neville BA, et al (2006). Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J National Cancer Inst, 98, 172-180. https://doi.org/10.1093/jnci/djj019
- Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang HJ (1992). The impact of subspecialty training on the management of advanced ovarian cancer. Gynecologic Oncol, 47, 203-9. https://doi.org/10.1016/0090-8258(92)90107-T
- Eltabbakh GH (2004). Recent advances in the management of women with ovarian cancer. Minerva ginecologica, 56, 81-9.
- Gadducci A, Ferdeghini M, Prontera C, et al (1992). The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecologic Oncol, 44, 147-154. https://doi.org/10.1016/0090-8258(92)90030-M
- Giede KC, Kieser K, Dodge J, Rosen B (2005). Who should operate on patients with ovarian cancer? An evidence-based review. Gynecologic Oncol, 99, 447-461. https://doi.org/10.1016/j.ygyno.2005.07.008
- Jacobs I, Oram D, Fairbanks J, et al (1990). A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstetrics Gynaecol, 97, 922-9. https://doi.org/10.1111/j.1471-0528.1990.tb02448.x
- Le T, Giede C, Salem S, Lefebvre G, Rosen B, et al (2009). Initial evaluation and referral guidelines for management of pelvic/ovarian masses. J Obstet Gynaecol Can, 31, 668-80.
- Le T, Krepart GV, Lotocki RJ, Heywood MS (1997). Does debulking surgery improve survival in biologically aggressive ovarian carcinoma? Gynecologic Oncol, 67, 208-214. https://doi.org/10.1006/gyno.1997.4839
- Lewandrowski K (2003). Managing utilization of new diagnostic tests. Clin Leadersh Manag Rev, 17, 318-24.
- Mayer AR, Chambers SK, Graves E, et al (1992). Ovarian cancer staging: does it require a gynecologic oncologist? Gynecologic Oncol, 47, 223-7. https://doi.org/10.1016/0090-8258(92)90110-5
- McGowan L (1993). Patterns of care in carcinoma of the ovary. Cancer, 71, 628-33.
- Moss EL, Hollingworth J, Reynolds TM (2005). The role of CA125 in clinical practice. J Clin Pathol, 58, 308-312. https://doi.org/10.1136/jcp.2004.018077
- Posadas EM, Davidson B, Kohn EC (2004). Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature. Current Opinion Oncol, 16, 478-484. https://doi.org/10.1097/00001622-200409000-00012
- Yavuzcan A, Caglar M, Ozgu E, et al (2013). Should cutoff values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations? Asian Pac J Cancer Prev, 14, 5455-9. https://doi.org/10.7314/APJCP.2013.14.9.5455
피인용 문헌
- Value of the Platelet to Lymphocyte Ratio in the Diagnosis of Ovarian Neoplasms in Adolescents vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2037